MRVIMaravai LifeSciences Holdings Inc - Ordinary Shares - Class A
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
570
Frequently Asked Questions
What is Market Cap of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
What is the 52-week high for Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
What is the 52-week low for Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
What is Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A stock price today?
What was Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A?
How many employess does Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A has?